What is NelDerm?
NelDerm is focused on enhancing patient care through its HeelP.O.D. device, a pressure offloading solution designed for improved heel access and visualization during medical procedures. The device's features include memory foam for comfort, a simple securement mechanism, and fluid-resistant materials, prioritizing hygiene and ease of use for healthcare professionals. The company targets critical care settings with the aim of preventing hospital-acquired pressure injuries and reducing the time spent on patient care tasks, ultimately contributing to better patient outcomes.
How much funding has NelDerm raised?
NelDerm has raised a total of $750K across 1 funding round:
Other Financing Round
$750K
Other Financing Round (2022): $750K with participation from MedTech Projects, Magnet, and Bounce
Key Investors in NelDerm
MedTech Projects
MedTech Projects is an entity focused on the innovation and safety of biomedical technologies, offering support and consulting for medical device certification and quality management systems. Their involvement suggests a strategic interest in the regulatory and safety aspects of NelDerm's product.
Magnet
MAGNET is dedicated to supporting manufacturers in Northeast Ohio, particularly small to medium-sized enterprises, by assisting with product design and operational improvements. Their participation indicates a focus on the manufacturing and scaling potential of NelDerm's innovative device.
Bounce
Bounce Innovation Hub is a nonprofit organization supporting entrepreneurs and startups in Northeast Ohio with essential skills, resources, and mentorship. Their backing of NelDerm highlights a commitment to fostering innovation and growth within the startup ecosystem.
What's next for NelDerm?
The substantial enterprise-level funding, including the recent major strategic investment, positions NelDerm for significant scaling and market penetration. This capital infusion is expected to accelerate product development, expand manufacturing capabilities, and bolster sales and marketing efforts. The company's focus on addressing critical needs in hospital-acquired pressure injury prevention suggests a strategic push to establish itself as a leader in the medical device sector, particularly within critical care environments. Future growth will likely involve broader adoption of the HeelP.O.D. device and potential development of complementary product lines.
See full NelDerm company page
